Core Viewpoint - The announcement details the verification and public disclosure of the incentive plan for stock options at Beijing Wandong Medical Technology Co., Ltd, ensuring compliance with relevant regulations and confirming the eligibility of the proposed incentive recipients [1][2]. Disclosure Situation - The company published the list of incentive recipients on March 22, 2025, on the Shanghai Stock Exchange website and other designated media, with an internal public notice period from March 28 to April 8, 2025, during which no objections were received [1]. Supervisory Board Verification Opinion - The supervisory board verified the qualifications of the proposed incentive recipients, confirming that all individuals listed meet the requirements set forth in the Company Law, Securities Law, and relevant regulations [2]. - The basic information of the proposed incentive recipients is accurate, with no instances of falsehood or significant misrepresentation [3]. - None of the proposed recipients fall under the disqualifying conditions outlined in Article 8 of the Management Measures, such as being deemed inappropriate by the stock exchange or regulatory authorities within the last 12 months [4]. - The proposed incentive recipients do not include independent directors, supervisors, or shareholders holding more than 5% of the company's shares, ensuring compliance with the incentive plan's criteria [4].
北京万东医疗科技股份有限公司监事会关于股票期权激励计划激励对象名单的核查意见及公示情况说明